Siemens Healthineers AG (VIE:SHL)
Austria
· Delayed Price · Currency is EUR 45.31
+0.54 (1.21%)
At close: Sep 26, 2025
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Imaging | 12.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Growth | 8.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics | 4.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Growth | -1.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Therapies | 2.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Therapies Growth | 4.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from | -262.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Growth | 34.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Varian | 3.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Varian Growth | 9.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| EMEA | 7.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | 1.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | 9.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | 11.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia and Australia Revenue (Pre-FY2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia and Australia Revenue (Pre-FY2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific Japan Revenue (Post-FY2022 Reporting) | 2.94B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific Japan Revenue (Post-FY2022 Reporting) Growth | 6.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 2.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -1.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Income Before Taxes | 2.58B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Income Before Taxes Growth | 14.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Income Before Taxes | 235.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Income Before Taxes Growth | 18.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Therapies Income Before Taxes | 338.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Therapies Income Before Taxes Growth | -22.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Income Before Taxes | -1.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Income Before Taxes Growth | -8.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Varian Income Before Taxes | 639.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Varian Income Before Taxes Growth | 19.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Equipment Book-to-Bill Ratio | 1.11 |
Log In |
Log In |
Log In |
Log In | Upgrade
|